{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:06:37Z","timestamp":1793113597437,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K02440X\/1"],"award-info":[{"award-number":["MR\/K02440X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Nigeria bears 25% of global malaria burden despite concerted efforts towards its control and elimination. The emergence of drug resistance to first line drugs, artemisinin combination therapies (ACTs), indicates an urgent need for continuous molecular surveillance of drug resistance especially in high burden countries where drug interventions are heavily relied on. This study describes mutations in\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      genes associated with drug resistance in malaria;\n                      <jats:italic>Pfk1<\/jats:italic>\n                      3,\n                      <jats:italic>Pfmdr1<\/jats:italic>\n                      ,\n                      <jats:italic>PfATPase6<\/jats:italic>\n                      and\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      in isolates obtained from 83 symptomatic malaria patients collected in August 2014, aged 1\u201361\u00a0years old from South-west Nigeria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Two\n                      <jats:italic>Pfmdr<\/jats:italic>\n                      1, N86 and Y184 variants were present at a prevalence of 56% and 13.25% of isolates respectively. There was one synonymous (S679S) and two non-synonymous (M699V, S769M) mutations in the\n                      <jats:italic>PATPase6<\/jats:italic>\n                      gene, while\n                      <jats:italic>Pfcrt<\/jats:italic>\n                      genotype (CVIET), had a prevalence of 45%. The\n                      <jats:italic>Pfk13<\/jats:italic>\n                      C580Y mutant allele was suspected by allelic discrimination in two samples with mixed genotypes although this could not be validated with independent isolation or additional methods. Our findings call for robust molecular surveillance of antimalarial drug resistance markers in west Africa especially with increased use of antimalarial drugs as prophylaxis for Covid-19.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13104-020-05334-5","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T07:03:50Z","timestamp":1603782230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria"],"prefix":"10.1186","volume":"13","author":[{"given":"Monday","family":"Tola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6860-3607","authenticated-orcid":false,"given":"Olumide","family":"Ajibola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Taiwo","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusesan","family":"Omidiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samson Taiwo","family":"Awolola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Amambua-Ngwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"5334_CR1","unstructured":"World Health Organisation. Malaria [Internet]. 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria."},{"issue":"5","key":"5334_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of Artemisinin Resistance in Plasmodium falciparum Malaria. N Engl J Med. 2014;371(5):411\u201323.","journal-title":"N Engl J Med"},{"issue":"4","key":"5334_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimd\u00e9","year":"2001","unstructured":"Djimd\u00e9 A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourt\u00e9 Y, et al. A molecular marker for Chloroquine-Resistant Falciparum Malaria. N Engl J Med. 2001;344(4):257\u201363.","journal-title":"N Engl J Med"},{"issue":"4","key":"5334_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000;6(4):861\u201371.","journal-title":"Mol Cell."},{"issue":"3","key":"5334_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1086\/338566","volume":"185","author":"JG Kublin","year":"2002","unstructured":"Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185(3):380\u20138.","journal-title":"J Infect Dis"},{"key":"5334_CR6","unstructured":"van Eijk AM, Larsen DA, Kayentao K, Koshy G, Slaughter DEC, Roper C, et al. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2019. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309918307321. Accessed 4 Apr 2019"},{"issue":"1","key":"5334_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","volume":"17","author":"K Genotype","year":"2019","unstructured":"Genotype K. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments\u2014a WWARN individual patient data meta-analysis. BMC Med. 2019;17(1):1.","journal-title":"BMC Med."},{"issue":"1","key":"5334_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13071-018-2762-3","volume":"11","author":"T Adams","year":"2018","unstructured":"Adams T, Ennuson NAA, Quashie NB, Futagbi G, Matrevi S, Hagan OCK, et al. Prevalence of Plasmodium falciparum delayed clearance associated polymorphisms in adaptor protein complex 2 mu subunit (pfap2mu) and ubiquitin specific protease 1 (pfubp1) genes in Ghanaian isolates. Parasit Vectors. 2018;11(1):175.","journal-title":"Parasit Vectors"},{"issue":"11","key":"5334_CR9","doi-asserted-by":"publisher","first-page":"e26005","DOI":"10.1371\/journal.pone.0026005","volume":"6","author":"S Borrmann","year":"2011","unstructured":"Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, et al. Declining responsiveness of plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan Coast Mueller I, editor. PLoS ONE. 2011;6(11):e26005.","journal-title":"PLoS ONE"},{"issue":"7","key":"5334_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nsmb947","volume":"12","author":"A-C Uhlemann","year":"2005","unstructured":"Uhlemann A-C, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, et al. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol. 2005;12(7):628\u20139.","journal-title":"Nat Struct Mol Biol"},{"issue":"6951","key":"5334_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nature01813","volume":"424","author":"U Eckstein-Ludwig","year":"2003","unstructured":"Eckstein-Ludwig U, Webb RJ, van Goethem IDA, East JM, Lee AG, Kimura M, et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature. 2003;424(6951):957\u201361.","journal-title":"Nature"},{"issue":"1","key":"5334_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-6851(00)00201-2","volume":"108","author":"MT Duraisingh","year":"2000","unstructured":"Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol. 2000;108(1):13\u201323.","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"5334_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0166-6851(93)90050-8","volume":"58","author":"G Snounou","year":"1993","unstructured":"Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58(2):283\u201392.","journal-title":"Mol Biochem Parasitol"},{"issue":"9501","key":"5334_CR14","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(05)67787-2","volume":"366","author":"R Jambou","year":"2005","unstructured":"Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, et al. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. The Lancet. 2005;366(9501):1960\u20133.","journal-title":"The Lancet"},{"issue":"1","key":"5334_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12879-018-3314-3","volume":"18","author":"KM Oyebola","year":"2018","unstructured":"Oyebola KM, Aina OO, Idowu ET, Olukosi YA, Ajibaye OS, Otubanjo OA, et al. A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether\/Lumefantrine treated Plasmodium falciparum in Nigeria. BMC Infect Dis. 2018;18(1):392.","journal-title":"BMC Infect Dis"},{"issue":"6220","key":"5334_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gnadig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347(6220):428\u201331.","journal-title":"Science"},{"issue":"8","key":"5334_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nbt.2925","volume":"32","author":"M Ghorbal","year":"2014","unstructured":"Ghorbal M, Gorman M, Macpherson CR, Martins RM, Scherf A, Lopez-Rubio J-J. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat Biotechnol. 2014;32(8):819\u201321.","journal-title":"Nat Biotechnol"},{"key":"5334_CR18","doi-asserted-by":"crossref","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana J-LM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020. https:\/\/www.nature.com\/articles\/s41591-020-1005-2. Accessed 19 Aug 2020","DOI":"10.1038\/s41591-020-1005-2"},{"issue":"6","key":"5334_CR19","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.4269\/ajtmh.14-0605","volume":"92","author":"A Ouattara","year":"2015","unstructured":"Ouattara A, Kone A, Adams M, Fofana B, Maiga AW, Hampton S, et al. Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara. Mali Am J Trop Med Hyg. 2015;92(6):1202\u20136.","journal-title":"Mali Am J Trop Med Hyg"},{"issue":"1","key":"5334_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1475-2875-11-131","volume":"11","author":"DR Pillai","year":"2012","unstructured":"Pillai DR, Lau R, Khairnar K, Lepore R, Via A, Staines HM, et al. Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections. Malar J. 2012;11(1):131.","journal-title":"Malar J"},{"issue":"6272","key":"5334_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/345255a0","volume":"345","author":"SJ Foote","year":"1990","unstructured":"Foote SJ, Kyle DE, Martin RK, Oduola AMJ, Forsyth K, Kemp DJ, et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature. 1990;345(6272):255\u20138.","journal-title":"Nature"},{"key":"5334_CR22","doi-asserted-by":"crossref","unstructured":"Amambua-Ngwa A, Okebe J, Mbye H, Ceesay S, El-Fatouri F, Joof F, et al. Sustained Ex Vivo Susceptibility of Plasmodium falciparum to Artemisinin Derivatives but Increasing Tolerance to Artemisinin Combination Therapy Partner Quinolines in The Gambia. Antimicrob Agents Chemother. 2017;61(12). https:\/\/aac.asm.org\/lookup\/doi\/10.1128\/AAC.00759-17. Accessed 17 Mar 2019","DOI":"10.1128\/AAC.00759-17"},{"issue":"1","key":"5334_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12936-019-2977-6","volume":"18","author":"MN Ikegbunam","year":"2019","unstructured":"Ikegbunam MN, Nkonganyi CN, Thomas BN, Esimone CO, Velavan TP, Ojurongbe O. Analysis of Plasmodium falciparum Pfcrt and Pfmdr1 genes in parasite isolates from asymptomatic individuals in Southeast Nigeria 11 years after withdrawal of chloroquine. Malar J. 2019;18(1):343.","journal-title":"Malar J"},{"issue":"4","key":"5334_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4269\/ajtmh.2005.72.410","volume":"72","author":"X Wang","year":"2005","unstructured":"Wang X, Mu J, Li G, Chen P, Guo X, Fu L, et al. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People\u2019s Republic of China. Am J Trop Med Hyg. 2005;72(4):410\u20134.","journal-title":"Am J Trop Med Hyg."},{"issue":"1","key":"5334_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/1475-2875-12-415","volume":"12","author":"A Mohammed","year":"2013","unstructured":"Mohammed A, Ndaro A, Kalinga A, Manjurano A, Mosha JF, Mosha DF, et al. Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania. Malar J. 2013;12(1):415.","journal-title":"Malar J"},{"issue":"1","key":"5334_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1475-2875-8-106","volume":"8","author":"L Mwai","year":"2009","unstructured":"Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, et al. Chloroquine resistance before and after its withdrawal in Kenya. Malar J. 2009;8(1):106.","journal-title":"Malar J"},{"issue":"12","key":"5334_CR27","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1086\/375419","volume":"187","author":"JG Kublin","year":"2003","unstructured":"Kublin JG, Cortese JF, Njunju EM, G Mukadam RA, Wirima JJ, Kazembe PN, et al. Reemergence of Chloroquine-Sensitive Plasmodium falciparum Malaria after Cessation of Chloroquine Use in Malawi. J Infect Dis. 2003;187(12):1870\u20135.","journal-title":"J Infect Dis."},{"issue":"2","key":"5334_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/infdis\/jiq038","volume":"203","author":"MT Alam","year":"2011","unstructured":"Alam MT, de Souza DK, Vinayak S, Griffing SM, Poe AC, Duah NO, et al. Selective Sweeps and Genetic Lineages of Plasmodium falciparum Drug -Resistant Alleles in Ghana. J Infect Dis. 2011;203(2):220\u20137.","journal-title":"J Infect Dis"},{"issue":"1","key":"5334_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1475-2875-13-120","volume":"13","author":"L Golassa","year":"2014","unstructured":"Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G. High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia. Malar J. 2014;13(1):120.","journal-title":"Malar J"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05334-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-020-05334-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05334-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T19:28:46Z","timestamp":1635276526000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05334-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5334"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05334-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-35555\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35555\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35555\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-35555\/v3","asserted-by":"object"}]},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study, IRB\/13\/218 was approved by the Institutional Review Board of the Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria. Written informed parent or guardian consent was obtained from all participants in the study. All individuals positive for malaria were treated with Arthemeter-Lumefantrine by a nurse or clinician.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"497"}}